Kimmel Cancer Center
African American Prostate Cancer Patients Get More VUS, Fewer Actionable Results, Studies Show
Research presented at ASCO's annual meeting underscores the need for more cancer susceptibility studies in diverse populations, experts say.
Exact Sciences, Jefferson Health to Study Blood-Based Multicancer Early Detection Test
The partners will survey doctors, care coordinators, and patients on metrics like test safety and efficacy, and how to best implement multicancer testing.
With the participation of five cancer centers and clinics, Taproot is hoping to build a national, prospective data registry that is much needed but has been difficult to advance to date.
Despite the step-up in FDA action against labs offering PGx tests, the success of these programs suggests that access to them isn't being stifled as some feared.
Circulating Tumor DNA Forecasts Recurrence in Non-Metastatic Colorectal Cancer
Two new studies of stage I to III CRC suggest that the presence of ctDNA in the months after surgery or chemotherapy can help identify patients who go on to relapse.